Thoracic amyloidomas: Two case reports of an evasive diagnosis

od Cresner, Rosie, Mahmood, Shameem, Chen, Jane, Rowan, Camilla, Wechalekar, Ashutosh D
Wydane 2014

Updates in Cardiac Amyloidosis: A Review

od Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane 2012

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c...

od Wechalekar, Ashutosh D., Gillmore, Julian D., Wassef, Nancy, Lachmann, Helen J., Whelan, Carol, Hawkins, Philip N.
Wydane 2011

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds

od Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.
Wydane w Eur J Nucl Med Mol Imaging (2018)

Two types of amyloid in a single heart

od Mahmood, Shameem, Gilbertson, Janet A., Rendell, Nigel, Whelan, Carol J., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.
Wydane w Blood (2014)

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis

od Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane w Blood Cancer J (2019)

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis

od Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane w Haematologica (2015)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria

od Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane w Haematologica (2020)

Natural history and outcome of light chain deposition disease

od Sayed, Rabya H., Wechalekar, Ashutosh D., Gilbertson, Janet A., Bass, Paul, Mahmood, Shameem, Sachchithanantham, Sajitha, Fontana, Marianna, Patel, Ketna, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Gillmore, Julian D.
Wydane w Blood (2015)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib

od Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane w Blood Cancer J (2021)

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis

od Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D
Wydane w J Pathol Clin Res (2019)

A prospective study of nutritional status in immunoglobulin light chain amyloidosis

od Sattianayagam, Prayman T., Lane, Thirusha, Fox, Zoe, Petrie, Aviva, Gibbs, Simon D.J., Pinney, Jennifer H., Risom, Signe S., Rowczenio, Dorota M., Wechalekar, Ashutosh D., Lachmann, Helen J., Gilbertson, Janet A., Hawkins, Philip N., Gillmore, Julian D.
Wydane 2013

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis

od Cohen, Oliver C., Law, Steven, Lachmann, Helen J., Sharpley, Faye, Ravichandran, Sriram, Mahmood, Shameem, Sachchithanantham, Sajitha, Whelan, Carol J., De Azcona Naharro, Ana Martinez, Fontana, Marianna, Hawkins, Philip N., Gillmore, Julian D., Wechalekar, Ashutosh D.
Wydane w Blood Cancer J (2020)

Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I

od Rowczenio, Dorota, Dogan, Ahmet, Theis, Jason D., Vrana, Julie A., Lachmann, Helen J., Wechalekar, Ashutosh D., Gilbertson, Janet A., Hunt, Toby, Gibbs, Simon D.J., Sattianayagam, Prayman T., Pinney, Jenny H., Hawkins, Philip N., Gillmore, Julian D.
Wydane 2011

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting

od Venner, Christopher P., Gillmore, Julian D., Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer H, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Wydane w Haematologica (2014)

Systemic Amyloidosis in England: an epidemiological study

od Pinney, Jennifer H, Smith, Colette J, Taube, Jessi B, Lachmann, Helen J, Venner, Christopher P, Gibbs, Simon D J, Dungu, Jason, Banypersad, Sanjay M, Wechalekar, Ashutosh D, Whelan, Carol J, Hawkins, Philip N, Gillmore, Julian D
Wydane w Br J Haematol (2013)

T1 mapping and survival in systemic light-chain amyloidosis

od Banypersad, Sanjay M., Fontana, Marianna, Maestrini, Viviana, Sado, Daniel M., Captur, Gabriella, Petrie, Aviva, Piechnik, Stefan K., Whelan, Carol J., Herrey, Anna S., Gillmore, Julian D., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Moon, James C.
Wydane w Eur Heart J (2015)

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

od Premkumar, Vikram J., Lentzsch, Suzanne, Pan, Samuel, Bhutani, Divaya, Richter, Joshua, Jagannath, Sundar, Liedtke, Michaela, Jaccard, Arnaud, Wechalekar, Ashutosh D., Comenzo, Raymond, Sanchorawala, Vaishali, Royer, Bruno, Rosenzweig, Michael, Valent, Jason, Schönland, Stefan, Fonseca, Rafael, Wong, Sandy, Kapoor, Prashant
Wydane w Blood Cancer J (2021)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

od Jaccard, Arnaud, Comenzo, Raymond L., Hari, Parameswaran, Hawkins, Philip N., Roussel, Murielle, Morel, Pierre, Macro, Margaret, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Mohty, Dania, Mercie, Patrick, Decaux, Olivier, Gillmore, Julian, Lavergne, David, Bridoux, Frank, Wechalekar, Ashutosh D., Venner, Christopher P.
Wydane w Haematologica (2014)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis

od Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.
Wydane w Eur Heart J (2017)